Prostate Disorders Clinical Trials

A listing of Prostate Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 338 clinical trials
A Study of CC-90011 and Comparators in Participants With Prostate Cancer

This is an open-label, positron emission tomography (PET) imaging Proof of Biology (POB) study to determine whether CC -90011 reverses, by the induction of androgen receptor (AR) expression, the castration resistance, due to lineage switch, in participants with mCRPC that have failed enzalutamide as last prior therapy. This study aims …

  • 0 views
  • 04 Oct, 2022
  • 1 location
MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer

This is a single-arm hybrid implementation trial of men with metastatic castrate-resistant prostate cancer (mCRPC) involving a patient-administered mobile app for consultation audio recordings

  • 0 views
  • 04 Oct, 2022
  • 1 location
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer (PR11)

The purpose of this research study is to determine if dose-escalated proton radiation therapy is a good way to treat high-risk prostate cancer. The study features hypofractionation and a

androgens
ct scan
cancer
androgen suppression
antiandrogen therapy
  • 4 views
  • 07 Oct, 2022
  • 1 location
Development and Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors

Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its

  • 0 views
  • 17 Oct, 2022
  • 1 location
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers (VA-BAT)

This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically unstable …

  • 0 views
  • 07 Oct, 2022
  • 12 locations
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

The purpose of this study is to find out whether combining a shorter than standard course of ADT with standard prostate brachytherapy and hypofractionated external beam radiation therapy is a

  • 0 views
  • 04 Oct, 2022
  • 7 locations
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer (CAPTAIN)

Men with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered

  • 36 views
  • 07 Oct, 2022
  • 8 locations
CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours

The hepatic enzyme, cytochrome P450 3A4 (CYP3A4) is important for the metabolism of many drugs including taxanes. Previous reported studies reported a decreases in docetaxel exposure in prostate

  • 0 views
  • 07 Oct, 2022
  • 1 location
Feasibility Study of Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) (RTIRE)

This is a single-site feasibility trial for 10 subjects with favorable intermediate risk prostate cancer who undergo Irreversible Electroporation (IRE) followed by Magnetic Resonance guided

  • 0 views
  • 04 Oct, 2022
  • 1 location
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle

Patient-blinded randomized controlled trial evaluating length and quality of prostate biopsies taken by a novel biopsy needle.

  • 0 views
  • 07 Oct, 2022
  • 1 location